StockData
Immatics N.V. logo

Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$5.77−0.18 (-3.03%)

Close on Nov 20, 2026Market cap $773.59MP/E –Yield –

Immatics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -€183.18M. The highest annual figure on record is €94.39M in fiscal 2022.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€183.18M–
FY2024Dec 31, 2024-€174.30M–
FY2023Dec 31, 2023-€12.57M-113.3%
FY2022Dec 31, 2022€94.39M–
FY2021Dec 31, 2021-€89.85M–
FY2020Dec 31, 2020-€88.12M-228.0%
FY2019Dec 31, 2019€68.82M+239.8%
FY2018Dec 31, 2018€20.26M–

More Immatics figures

See a number that looks wrong?